Teva Pharmaceutical Industries
TEVA
#532
Rank
$45.84 B
Marketcap
$39.31
Share price
-0.73%
Change (1 day)
95.96%
Change (1 year)

P/S ratio for Teva Pharmaceutical Industries (TEVA)

P/S ratio as of October 2026 (TTM): 2.65

According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.91. At the end of 2026 the company had a P/S ratio of 2.23.

P/S ratio history for Teva Pharmaceutical Industries from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.238.55%
20252.0631.94%
20241.56108.57%
20230.747710.16%
20220.678721.97%
20210.5564-10.99%
20200.6251-4.94%
20190.6576-26.92%
20180.89984.81%
20170.8585-48.89%
20161.68-44.21%
20153.0125.69%
20142.4044.02%
20131.666.12%
20121.57-19.45%
20111.95-32.94%
20102.90-18.91%
20093.584.86%
20083.41-14.5%
20073.9936.19%
20062.93-44.67%
20055.3035.81%
20043.90-18.84%
20034.8121.21%
20023.974.34%
20013.80

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
4.73 78.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.52-4.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.71-35.26%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
5.33 101.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
3.99 50.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.13-19.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
2.82 6.52%๐Ÿ‡ฎ๐Ÿ‡ณ India